Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1480

1.

The distribution of prostate cancer recurrences on 68 Ga-PSMA PET/CT after radical prostatectomy with pathological node positive extended lymph node dissection.

Huits TH, Luiting HB, van der Poel H, Nandurkar R, Donswijk M, Schaake E, Vogel W, Roobol MJ, Wit E, Stricker P, Emmett L, van Leeuwen PJ.

BJU Int. 2020 Mar 17. doi: 10.1111/bju.15052. [Epub ahead of print]

PMID:
32181951
2.

Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer.

Liskamp CP, Donswijk ML, van der Poel HG, Schaake EE, Vogel WV.

Clin Transl Radiat Oncol. 2020 Feb 26;22:9-14. doi: 10.1016/j.ctro.2020.02.006. eCollection 2020 May.

3.

Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?

Konert T, Everitt S, La Fontaine MD, van de Kamer JB, MacManus MP, Vogel WV, Callahan J, Sonke JJ.

PLoS One. 2020 Feb 25;15(2):e0228793. doi: 10.1371/journal.pone.0228793. eCollection 2020.

4.

EVI1 as a Marker for Lymph Node Metastasis in HNSCC.

Idel C, Ribbat-Idel J, Kuppler P, Krupar R, Offermann A, Vogel W, Rades D, Kirfel J, Wollenberg B, Perner S.

Int J Mol Sci. 2020 Jan 28;21(3). pii: E854. doi: 10.3390/ijms21030854.

5.

Detector-Agnostic Phase-Space Distributions.

Sperling J, Phillips DS, Bulmer JFF, Thekkadath GS, Eckstein A, Wolterink TAW, Lugani J, Nam SW, Lita A, Gerrits T, Vogel W, Agarwal GS, Silberhorn C, Walmsley IA.

Phys Rev Lett. 2020 Jan 10;124(1):013605. doi: 10.1103/PhysRevLett.124.013605.

PMID:
31976720
6.

Push-pull thiophene chromophores for electro-optic applications: from 1D linear to β-branched structures.

Rothe C, Neusser D, Hoppe N, Dirnberger K, Vogel W, Gámez-Valenzuela S, López Navarrete JT, Villacampa B, Berroth M, Ruiz Delgado MC, Ludwigs S.

Phys Chem Chem Phys. 2020 Jan 28;22(4):2283-2294. doi: 10.1039/c9cp05640h. Epub 2020 Jan 10.

PMID:
31922173
7.

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience.

Roerden M, Sökler M, Kanz L, Bethge W, Vogel W, Walz JS.

Ann Hematol. 2020 Feb;99(2):265-276. doi: 10.1007/s00277-019-03900-x. Epub 2020 Jan 2.

PMID:
31897675
8.

Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC.

van Diessen JNA, La Fontaine M, van den Heuvel MM, van Werkhoven E, Walraven I, Vogel WV, Belderbos JSA, Sonke JJ.

Radiother Oncol. 2020 Feb;143:30-36. doi: 10.1016/j.radonc.2019.10.008. Epub 2019 Nov 22.

PMID:
31767474
9.

Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.

de Veij Mestdagh PD, Schreuder WH, Vogel WV, Donswijk ML, van Werkhoven E, van der Wal JE, Dirven R, Karakullukcu B, Sonke JJ, van den Brekel MWM, Marijnen CAM, Al-Mamgani A.

BMC Cancer. 2019 Nov 14;19(1):1110. doi: 10.1186/s12885-019-6331-8.

10.

The Wellness Incentive and Navigation intervention improved health-related quality of life among Medicaid enrollees: A randomized pragmatic clinical trial.

Guo Y, Vogel WB, Muller KE, Stoner D, Huo T, Shenkman EA.

Health Serv Res. 2019 Dec;54(6):1156-1165. doi: 10.1111/1475-6773.13235. Epub 2019 Oct 22.

PMID:
31642066
11.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

Beelen DW, Trenschel R, Stelljes M, Groth C, Masszi T, Reményi P, Wagner-Drouet EM, Hauptrock B, Dreger P, Luft T, Bethge W, Vogel W, Ciceri F, Peccatori J, Stölzel F, Schetelig J, Junghanß C, Grosse-Thie C, Michallet M, Labussiere-Wallet H, Schaefer-Eckart K, Dressler S, Grigoleit GU, Mielke S, Scheid C, Holtick U, Patriarca F, Medeot M, Rambaldi A, Micò MC, Niederwieser D, Franke GN, Hilgendorf I, Winkelmann NR, Russo D, Socié G, Peffault de Latour R, Holler E, Wolff D, Glass B, Casper J, Wulf G, Menzel H, Basara N, Bieniaszewska M, Stuhler G, Verbeek M, Grass S, Iori AP, Finke J, Benedetti F, Pichlmeier U, Hemmelmann C, Tribanek M, Klein A, Mylius HA, Baumgart J, Dzierzak-Mietla M, Markiewicz M.

Lancet Haematol. 2020 Jan;7(1):e28-e39. doi: 10.1016/S2352-3026(19)30157-7. Epub 2019 Oct 9.

PMID:
31606445
12.

Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study.

Willmann M, Vehreschild MJGT, Biehl LM, Vogel W, Dörfel D, Hamprecht A, Seifert H, Autenrieth IB, Peter S.

BMC Biol. 2019 Sep 18;17(1):76. doi: 10.1186/s12915-019-0692-y.

13.

The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.

Roerden M, Walz JS, Müller MR, Sökler M, Federmann B, Kanz L, Bethge W, Vogel W.

J Cancer Res Clin Oncol. 2019 Oct;145(10):2595-2604. doi: 10.1007/s00432-019-02999-9. Epub 2019 Aug 13.

PMID:
31410605
14.

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.

Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D, Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate Cancer Working Group, Busstra M, de Jong IJ, de Reijke T, de Vries K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E, Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van Moorselaar J, van Oort I, Vogel W, Westgeest H.

Eur Urol Oncol. 2019 Aug 7. pii: S2588-9311(19)30113-0. doi: 10.1016/j.euo.2019.07.010. [Epub ahead of print]

PMID:
31401014
15.

Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients.

Kuempers C, van der Linde LIS, Reischl M, Vogel W, Stellmacher F, Reck M, Heigener D, Rabe KF, Kirfel J, Perner S, Welker L.

Virchows Arch. 2020 Feb;476(2):261-271. doi: 10.1007/s00428-019-02632-7. Epub 2019 Aug 7.

PMID:
31392467
16.

Introducing FDG PET/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial.

Konert T, Vogel WV, Paez D, Polo A, Fidarova E, Carvalho H, Duarte PS, Zuliani AC, Santos AO, Altuhhova D, Karusoo L, Kapoor R, Sood A, Khader J, Al-Ibraheem A, Numair Y, Abubaker S, Soydal C, Kütük T, Le TA, Canh NX, Bieu BQ, Ha LN, Belderbos JSA, MacManus MP, Thorwarth D, Hanna GG.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2235-2243. doi: 10.1007/s00259-019-04421-5. Epub 2019 Jul 31.

17.

Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR).

Dimitriou V, Biehl LM, Hamprecht A, Vogel W, Dörfel D, Peter S, Schafhausen P, Rohde H, von Lilienfeld-Toal M, Klassert TE, Slickers P, Ehricht R, Slevogt H, Christ H, Hellmich M, Farowski F, Tsakmaklis A, Higgins PG, Seifert H, Vehreschild MJGT.

J Antimicrob Chemother. 2019 Jul 1;74(7):2065-2074. doi: 10.1093/jac/dkz124.

PMID:
31220256
18.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

J Adv Pract Oncol. 2018 Sep-Oct;9(6):585-598. Epub 2018 Sep 1. Review.

19.

Integrated versus separate reading of F-18 FDG-PET/CT and MRI for abdominal malignancies - effect on staging outcomes and diagnostic confidence.

Min LA, Vogel WV, Lahaye MJ, Maas M, Donswijk ML, Vegt E, Kusters M, Zijlmans HJ, Jóźwiak K, Roberti S, Beets-Tan RGH, Lambregts DMJ.

Eur Radiol. 2019 Dec;29(12):6900-6910. doi: 10.1007/s00330-019-06253-1. Epub 2019 May 22.

PMID:
31119418
20.

Retrospective single center analysis of outcome, risk factors and therapy in steroid refractory graft-versus-host disease after allogeneic hematopoietic cell transplantation.

Axt L, Naumann A, Toennies J, Haen SP, Vogel W, Schneidawind D, Wirths S, Moehle R, Faul C, Kanz L, Axt S, Bethge WA.

Bone Marrow Transplant. 2019 Nov;54(11):1805-1814. doi: 10.1038/s41409-019-0544-y. Epub 2019 May 14.

PMID:
31089279
21.

Presenting With Confidence.

Vogel WH, Viale PH.

J Adv Pract Oncol. 2018 Jul-Aug;9(5):545-548. Epub 2018 Jul 1. Review.

22.

A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.

Goos JAC, Vogel WK, Mlcochova H, Millard CJ, Esfandiari E, Selman WH, Calpena E, Koelling N, Carpenter EL, Swagemakers SMA, van der Spek PJ, Filtz TM, Schwabe JWR, Iwaniec UT, Mathijssen IMJ, Leid M, Twigg SRF.

Hum Mol Genet. 2019 Apr 3. pii: ddz072. doi: 10.1093/hmg/ddz072. [Epub ahead of print]

23.

Incidence of contralateral regional failure in the electively irradiated contralateral neck of patients with head and neck squamous cell carcinoma.

de Veij Mestdagh PD, van Werkhoven E, Navran A, de Boer JP, Schreuder WH, Vogel WV, Al-Mamgani A.

Clin Transl Radiat Oncol. 2019 Apr 19;17:7-13. doi: 10.1016/j.ctro.2019.04.015. eCollection 2019 Jul.

24.

A Mother in Jeopardy: The Ethics of Pregnancy and Chemotherapy.

Baumrucker SJ, Vogel WH, Stolick RM, Adkins RW, Holland H, VandeKieft G, Eastridge A.

Am J Hosp Palliat Care. 2020 Jan;37(1):72-78. doi: 10.1177/1049909119846861. Epub 2019 Apr 28.

PMID:
31030526
25.

Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome.

Aalbersberg EA, Rossi MM, de Wit-van der Veen LJ, Walraven I, van den Heuvel MM, Sonke JJ, Belderbos JS, Vogel WV.

Radiother Oncol. 2019 May;134:30-36. doi: 10.1016/j.radonc.2019.01.015. Epub 2019 Jan 31.

PMID:
31005221
26.

Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma.

Kümpers C, Jokic M, Haase O, Offermann A, Vogel W, Grätz V, Langan EA, Perner S, Terheyden P.

Front Med (Lausanne). 2019 Mar 13;6:27. doi: 10.3389/fmed.2019.00027. eCollection 2019.

27.

The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.

Gouw ZAR, La Fontaine MD, van Kranen S, van de Kamer JB, Vogel WV, van Werkhoven E, Sonke JJ, Al-Mamgani A.

Clin Nucl Med. 2019 May;44(5):e323-e328. doi: 10.1097/RLU.0000000000002531.

PMID:
30889002
28.

Expansion of Vancomycin-Resistant Enterococcus faecium in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation.

Liese J, Schüle L, Oberhettinger P, Tschörner L, Nguyen T, Dörfel D, Vogel W, Marschal M, Autenrieth I, Willmann M, Peter S.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e01978-18. doi: 10.1128/AAC.01978-18. Print 2019 May.

29.

Parotidectomy in patients with head and neck cutaneous melanoma with cervical lymph node involvement.

Berger DMS, van Veen MM, Madu MF, van Akkooi ACJ, Vogel WV, Balm AJM, Klop WMC.

Head Neck. 2019 Jul;41(7):2264-2270. doi: 10.1002/hed.25670. Epub 2019 Feb 14.

PMID:
30762921
30.

FDG-PET/CT improves detection of residual disease and reduces the need for examination under anaesthesia in oropharyngeal cancer patients treated with (chemo-)radiation.

de Ridder M, Gouw ZAR, Navran A, Hamming-Vrieze O, Jasperse B, van den Brekel MWM, Vogel WV, Al-Mamgani A.

Eur Arch Otorhinolaryngol. 2019 May;276(5):1447-1455. doi: 10.1007/s00405-019-05340-9. Epub 2019 Feb 13.

PMID:
30758660
31.

Image Guided Evolution of Nodal Contouring Guidelines in Breast Cancer.

Bergom C, Vogel WV.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):592-594. doi: 10.1016/j.ijrobp.2018.10.037. No abstract available.

PMID:
30722970
32.

Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards.

Biehl LM, Higgins P, Wille T, Peter K, Hamprecht A, Peter S, Dörfel D, Vogel W, Häfner H, Lemmen S, Panse J, Rohde H, Klupp EM, Schafhausen P, Imirzalioglu C, Falgenhauer L, Salmanton-García J, Stecher M, Vehreschild JJ, Seifert H, Vehreschild MJGT.

Clin Microbiol Infect. 2019 Aug;25(8):1013-1020. doi: 10.1016/j.cmi.2018.12.029. Epub 2019 Jan 12.

PMID:
30641228
33.

A mechanistic classification of clinical phenotypes in neuroblastoma.

Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, Bartenhagen C, Walter E, Gecht J, Kerschke L, Volland R, Menon R, Heuckmann JM, Gartlgruber M, Hartlieb S, Henrich KO, Okonechnikov K, Altmüller J, Nürnberg P, Lefever S, de Wilde B, Sand F, Ikram F, Rosswog C, Fischer J, Theissen J, Hertwig F, Singhi AD, Simon T, Vogel W, Perner S, Krug B, Schmidt M, Rahmann S, Achter V, Lang U, Vokuhl C, Ortmann M, Büttner R, Eggert A, Speleman F, O'Sullivan RJ, Thomas RK, Berthold F, Vandesompele J, Schramm A, Westermann F, Schulte JH, Peifer M, Fischer M.

Science. 2018 Dec 7;362(6419):1165-1170. doi: 10.1126/science.aat6768.

PMID:
30523111
34.

Understanding the role of advanced practice providers in oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

JAAPA. 2018 Dec;31(12):1-12. doi: 10.1097/01.JAA.0000549592.10756.4a. Review.

PMID:
30489397
35.

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression.

Torgovnick A, Heger JM, Liaki V, Isensee J, Schmitt A, Knittel G, Riabinska A, Beleggia F, Laurien L, Leeser U, Jüngst C, Siedek F, Vogel W, Klümper N, Nolte H, Wittersheim M, Tharun L, Castiglione R, Krüger M, Schauss A, Perner S, Pasparakis M, Büttner R, Persigehl T, Hucho T, Herter-Sprie GS, Schumacher B, Reinhardt HC.

Cell Rep. 2018 Oct 23;25(4):1027-1039.e6. doi: 10.1016/j.celrep.2018.09.079.

36.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge S, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

Oncol Nurs Forum. 2018 Nov 1;45(6):786-800. doi: 10.1188/18.ONF.786-800.

PMID:
30339144
37.

Hepatitis C Virus in the Hematology/Oncology Patient.

Vogel WH.

J Adv Pract Oncol. 2017 Nov-Dec;8(7):765-772. Epub 2017 Nov 1. Review. No abstract available.

38.

Li-Fraumeni Syndrome.

Vogel WH.

J Adv Pract Oncol. 2017 Nov-Dec;8(7):742-746. Epub 2017 Nov 1. Review. No abstract available.

39.

The Oncology Care Model for Advanced Practitioners.

Vogel WH.

J Adv Pract Oncol. 2017 Sep-Oct;8(6):655-656. Epub 2017 Sep 1. Review. No abstract available.

40.

Managing Drug Interactions in Cancer Therapy: A Guide for the Advanced Practitioner.

Campen CJ, Vogel WH, Shah PJ.

J Adv Pract Oncol. 2017 Sep-Oct;8(6):609-620. Epub 2017 Sep 1. Review.

41.

Impact of bariatric surgery on neural food processing and cognition: an fMRI study.

Schulze M, Sörös P, Vogel W, Münte TF, Müller HHO, Philipsen A.

BMJ Open. 2018 Sep 28;8(9):e022375. doi: 10.1136/bmjopen-2018-022375.

42.

The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.

Konert T, van de Kamer JB, Sonke JJ, Vogel WV.

J Thorac Dis. 2018 Aug;10(Suppl 21):S2508-S2521. doi: 10.21037/jtd.2018.07.101. Review.

43.

Understanding the Role of Advanced Practice Providers in Oncology in the United States.

Bruinooge SS, Pickard TA, Vogel W, Hanley A, Schenkel C, Garrett-Mayer E, Tetzlaff E, Rosenzweig M, Hylton H, Westin SN, Smith N, Lynch C, Kosty MP, Williams SF.

J Oncol Pract. 2018 Sep;14(9):e518-e532. doi: 10.1200/JOP.18.00181. Epub 2018 Aug 22. Erratum in: J Oncol Pract. 2019 Jan;15(1):60.

PMID:
30133346
44.

SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.

de Veij Mestdagh PD, Janssen T, Lamers E, Carbaat C, Hamming-Vrieze O, Vogel WV, Sonke JJ, Al-Mamgani A.

Radiother Oncol. 2019 Jan;130:18-24. doi: 10.1016/j.radonc.2018.07.023. Epub 2018 Aug 4.

PMID:
30087057
45.

SPECT/CT-guided lymph drainage mapping for the planning of unilateral elective nodal irradiation in head and neck squamous cell carcinoma.

de Veij Mestdagh PD, Jonker MCJ, Vogel WV, Schreuder WH, Donswijk ML, Klop WMC, Al-Mamgani A.

Eur Arch Otorhinolaryngol. 2018 Aug;275(8):2135-2144. doi: 10.1007/s00405-018-5050-0. Epub 2018 Jun 28.

PMID:
29955968
46.

Biological PET-guided adaptive radiotherapy for dose escalation in head and neck cancer: a systematic review.

Hamming-Vrieze O, Navran A, Al-Mamgani A, Vogel WV.

Q J Nucl Med Mol Imaging. 2018 Dec;62(4):349-368. doi: 10.23736/S1824-4785.18.03087-X. Epub 2018 Jun 4.

47.

Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation.

van den Bosch S, Vogel WV, Raaijmakers CP, Dijkema T, Terhaard CHJ, Al-Mamgani A, Kaanders JHAM.

Radiother Oncol. 2018 Sep;128(3):472-478. doi: 10.1016/j.radonc.2018.04.020. Epub 2018 May 3. Review.

48.

A secondary analysis of FDG spatio-temporal consistency in the randomized phase II PET-boost trial in stage II-III NSCLC.

La Fontaine M, Vogel W, van Diessen J, van Elmpt W, Reymen B, Persson G, Westman G, De Ruysscher D, Belderbos J, Sonke JJ.

Radiother Oncol. 2018 May;127(2):259-266. doi: 10.1016/j.radonc.2018.03.020. Epub 2018 Apr 27.

PMID:
29709378
49.

Identification of nonclassical properties of light with multiplexing layouts.

Sperling J, Eckstein A, Clements WR, Moore M, Renema JJ, Kolthammer WS, Nam SW, Lita A, Gerrits T, Walmsley IA, Agarwal GS, Vogel W.

Phys Rev A (Coll Park). 2017 Jul;96(1). pii: 013804. doi: 10.1103/PhysRevA.96.013804. Epub 2017 Jul 6.

50.

Renal and Hematologic Comparative Effects of Dissociated Agonist of the Glucocorticoid Receptor and Prednisone in Dogs With and Without Food Restriction.

Radi ZA, Vogel WM, LaBranche T, Dybowski JA, Peraza MA, Portugal SS, Lettiere DJ.

Int J Toxicol. 2018 May/Jun;37(3):223-233. doi: 10.1177/1091581818763804. Epub 2018 Mar 19.

PMID:
29554821

Supplemental Content

Support Center